tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IO Biotech Advances Cancer Vaccine Trials in Q1 2025
PremiumCompany AnnouncementsIO Biotech Advances Cancer Vaccine Trials in Q1 2025
2M ago
IO Biotech: Promising Future with Strong Clinical Progress and Financial Backing
Premium
Ratings
IO Biotech: Promising Future with Strong Clinical Progress and Financial Backing
2M ago
Optimistic Outlook on IO Biotech: Promising Cancer Treatment Developments and Strategic Growth Moves
Premium
Ratings
Optimistic Outlook on IO Biotech: Promising Cancer Treatment Developments and Strategic Growth Moves
2M ago
IOBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsIOBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating
Premium
Ratings
Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating
5M ago
IO Biotech Advances Phase 3 Trial and Secures Financing
Premium
Company Announcements
IO Biotech Advances Phase 3 Trial and Secures Financing
5M ago
IO Biotech reports Q3 EPS (36c), consensus (29c)
PremiumThe FlyIO Biotech reports Q3 EPS (36c), consensus (29c)
8M ago
IO Biotech sees cash runway into 4Q25
Premium
The Fly
IO Biotech sees cash runway into 4Q25
8M ago
IO Biotech reports data on IO102-IO103 vaccine in combination with KEYTRUDA
Premium
The Fly
IO Biotech reports data on IO102-IO103 vaccine in combination with KEYTRUDA
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100